Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

MedCity FemFwd: Inside Partum Health’s Partnership with UChicago Medicine
NewsApr 30, 2026

MedCity FemFwd: Inside Partum Health’s Partnership with UChicago Medicine

Partum Health has partnered with UChicago Medicine in Hyde Park to provide 24/7, Medicaid‑reimbursed doula support for labor, delivery, and postpartum care. The program offers in‑person doulas without referrals, aiming to improve birth outcomes and patient satisfaction for a largely Medicaid‑eligible...

By MedCity News
People in Low-Income Areas Are Less Likely to Get Cancer Screenings
NewsApr 30, 2026

People in Low-Income Areas Are Less Likely to Get Cancer Screenings

A new study of 1,300 federally qualified health centers (FQHCs) serving 29.8 million patients reveals stark gaps in cancer screening rates across socioeconomic lines. Residents of the most resource‑poor neighborhoods receive colorectal screening about 15 percentage points less, breast screening 11 points less,...

By Futurity
Cybersecurity Tactics for Medical IoT Devices
NewsApr 30, 2026

Cybersecurity Tactics for Medical IoT Devices

The Internet of Medical Things (IoMT) is projected to surge from $60 billion in 2024 to $814 billion by 2032, driven by real‑time patient monitoring and cost‑saving benefits. However, 2024 saw over 14,000 IoMT IPs exposed, with 36% stemming from unsecured medical...

By MedTech Intelligence
The Prostate Cancer Recovery Few Men Are Warned About
BlogApr 30, 2026

The Prostate Cancer Recovery Few Men Are Warned About

Physiatrist Dr. Francisco M. Torres, a prostate‑cancer survivor, recounts his unexpected post‑operative challenges after robot‑assisted radical prostatectomy. His experience revealed a systemic failure: patients receive scant guidance on pre‑habilitation and pelvic‑floor rehabilitation, despite strong evidence that these interventions improve continence...

By KevinMD
Sorting Through Medicare Myths in Federal Retirement Decisions
NewsApr 30, 2026

Sorting Through Medicare Myths in Federal Retirement Decisions

Federal retirees face a maze of Medicare myths that can affect their health‑care costs. Adding Medicare Part B costs a base $202.90 per month, but many FEHB plans waive deductibles, copays and coinsurance when Medicare is primary, potentially offsetting the premium....

By GovExec
Asembia ASX26: The Strain on the Development of Infrastructure for Sustainable C&G Therapy
BlogApr 30, 2026

Asembia ASX26: The Strain on the Development of Infrastructure for Sustainable C&G Therapy

Cell and gene therapies promise transformative treatments but remain hampered by steep costs across research, manufacturing, and delivery. At the Asembia ASX26 Summit, Aradigm Health CEO Will Shrank highlighted the fragmented U.S. payment landscape as a core barrier to sustainable...

By Pharmaceutical Executive (independent trade outlet)
FDA's Oncology Advisors Vote Against 'New Paradigm' In AstraZeneca Trial
NewsApr 30, 2026

FDA's Oncology Advisors Vote Against 'New Paradigm' In AstraZeneca Trial

The FDA’s oncology advisory committee voted 6‑3 that AstraZeneca’s late‑stage trial of camizestrant, an oral selective estrogen‑receptor degrader (SERD), did not demonstrate a clinically meaningful benefit. AstraZeneca had positioned camizestrant as a potential first‑in‑class oral therapy for hormone‑receptor‑positive metastatic breast...

By Endpoints News
Siemens Healthineers to Receive $60M in Federal Funding for Key Cancer Therapy
NewsApr 30, 2026

Siemens Healthineers to Receive $60M in Federal Funding for Key Cancer Therapy

Siemens Healthineers will receive up to $60 million from ARPA‑H over five years, complemented by a $23 million cost‑share, totaling about $83 million. The funding targets development of photon flash therapy, an experimental radiation technique that delivers doses 100 times faster than conventional methods...

By Radiology Business
Task Switching Raises Risk in Transplant Surgeries, Study Finds
NewsApr 30, 2026

Task Switching Raises Risk in Transplant Surgeries, Study Finds

A Virginia Tech analysis of more than 300,000 transplant operations shows that surgeons who switch organ types between consecutive procedures raise one‑year patient mortality by 14.8%. The risk spikes when the switch occurs on the same day, lifting mortality from 4.5%...

By Medical Xpress
Higher Tubular Phosphate Levels Linked to Faster Five-Year Kidney Decline
NewsApr 30, 2026

Higher Tubular Phosphate Levels Linked to Faster Five-Year Kidney Decline

Researchers at the University of Tsukuba analyzed 308 Japanese participants and found that higher estimated proximal tubular fluid phosphate (ePTFp) levels are linked to a faster decline in kidney function over five years. The ePTFp metric, derived from routine serum...

By Medical Xpress
Scaling the Agentforce Life Sciences Ecosystem to Drive the Future of Pharma and MedTech
NewsApr 30, 2026

Scaling the Agentforce Life Sciences Ecosystem to Drive the Future of Pharma and MedTech

Salesforce announced a major expansion of its Agentforce Life Sciences ecosystem, forging deeper collaborations with global systems integrators, content partners, and independent software vendors to accelerate adoption of the Agentforce 360 platform. Leading SIs such as Accenture, Deloitte Digital, Cognizant...

By Salesforce Blog (Sales/CRM)
States Modernize PA Practice Laws to Expand Healthcare Workforces
NewsApr 30, 2026

States Modernize PA Practice Laws to Expand Healthcare Workforces

A wave of state legislation is expanding physician assistant (PA) autonomy as part of the federal Rural Health Transformation Program (RHTP). Seven states, including Iowa and Kentucky, have removed mandatory supervisory agreements, allowing PAs to practice independently and, in Kentucky,...

By Healthcare IT News (HIMSS Media)
From Toddlers to Teens:  The Hidden Complexities of Bringing Pediatric Wearables to Market
NewsApr 30, 2026

From Toddlers to Teens: The Hidden Complexities of Bringing Pediatric Wearables to Market

Pediatric wearables face unique challenges beyond miniaturization, requiring designs that adapt to rapidly changing physiological, cognitive, and behavioral traits from infancy to adolescence. Companies must address divergent safety, usability, data reliability, and algorithm performance needs across developmental stages, while managing...

By MedTech Intelligence
Heart Rhythm 2026: Electrophysiologist Mina Chung Discusses CPR, PFA and Much More
NewsApr 30, 2026

Heart Rhythm 2026: Electrophysiologist Mina Chung Discusses CPR, PFA and Much More

At Heart Rhythm 2026, HRS President Mina Chung outlined a multi‑pronged agenda that includes a new task force to expand CPR and AED training in high schools, leveraging digital‑health apps for continuous skill retention. The society also launched a real‑world...

By Cardiovascular Business
Trump Withdraws Wellness Influencer and MAHA Activist Casey Means as Surgeon General Nominee
NewsApr 30, 2026

Trump Withdraws Wellness Influencer and MAHA Activist Casey Means as Surgeon General Nominee

President Donald Trump withdrew wellness influencer Casey Means from the surgeon‑general nomination and named radiologist and Fox News contributor Nicole Saphier as his third pick. Means faced Senate opposition over her anti‑vaccine, abortion‑pill, and alternative‑medicine positions, while Saphier brings clinical...

By Scientific American – Mind
Healthcare Affordability Part 4: How Annuitants Can Use Expected Healthcare Costs  to Help Choose the Right Health Plan
NewsApr 30, 2026

Healthcare Affordability Part 4: How Annuitants Can Use Expected Healthcare Costs to Help Choose the Right Health Plan

Retirees who receive federal annuities must navigate Medicare Parts A and B while deciding between traditional FEHB coverage, Medicare Advantage (MA) offered through FEHB carriers, or commercial MA plans that require suspending FEHB. Part B carries a $202.90 monthly premium, with...

By Federal News Network
After Reductions, VA Chief Says Facilities Can 'Hire Where They Need and What They Need'
NewsApr 30, 2026

After Reductions, VA Chief Says Facilities Can 'Hire Where They Need and What They Need'

Veterans Affairs Secretary Doug Collins told the Senate Appropriations Committee that no VA facility faces hiring constraints, despite the department’s recent staffing caps and a 30,000‑person workforce reduction. He emphasized that baseline FTE limits are administrative and will not block...

By GovExec
Ride in Support of People Living with Diabetes at the 2026 Tour De Cure: Pacific Northwest
NewsApr 30, 2026

Ride in Support of People Living with Diabetes at the 2026 Tour De Cure: Pacific Northwest

On May 2, 2026 the American Diabetes Association will host the Tour de Cure Pacific Northwest in Bothell, Washington. The one‑day cycling fundraiser expects 168 participants to ride from 7 a.m. to 2 p.m., raising money for diabetes research, advocacy and local programming....

By American Diabetes Association – Diabetes Food Hub/Blog
Genmab A/S (NASDAQ:GMAB) Upgraded at Truist Financial
NewsApr 30, 2026

Genmab A/S (NASDAQ:GMAB) Upgraded at Truist Financial

Truist Financial upgraded Danish biotech Genmab A/S (NASDAQ:GMAB) to a strong‑buy, joining recent upgrades from Goldman Sachs and BNP Paribas. The stock currently trades around $26.11, well below its 52‑week high of $35.43, with a market cap of $16.78 billion and a...

By DefenseWorld/DW
Doctors Agree: There’s a Lot to Love About Cardiology’s Future
NewsApr 30, 2026

Doctors Agree: There’s a Lot to Love About Cardiology’s Future

A Medscape survey of nearly 6,000 U.S. physicians shows 59% of cardiologists are optimistic about the short‑term outlook and 48% about the long‑term, placing cardiology in the top ten specialties for confidence. Only 10% express short‑term pessimism and 24% long‑term...

By Cardiovascular Business
Vaccine Hesitancy in an Era of Misinformation
NewsApr 30, 2026

Vaccine Hesitancy in an Era of Misinformation

The CDC revised its autism‑vaccine statement in November 2025, moving from a definitive “no link” stance to an uncertainty‑based message. A Science‑journal survey of 2,900 U.S. adults found that exposure to the new wording raised perceived vaccine risks and lowered...

By Nautilus
Communication From the CDC Fuels Skepticism About Vaccines and Science, Research Suggests
NewsApr 30, 2026

Communication From the CDC Fuels Skepticism About Vaccines and Science, Research Suggests

The CDC altered its website language to suggest that a link between vaccines and autism cannot be ruled out, diverging from the long‑standing consensus that no causal relationship exists. An international team led by the University of Vienna surveyed 2,989...

By Medical Xpress
Caregivers of Ovarian Cancer Patients Face High Stress and Major Gaps in Support
NewsApr 30, 2026

Caregivers of Ovarian Cancer Patients Face High Stress and Major Gaps in Support

A scoping review by the University of Toronto, published in PLOS One, examined 32 studies over 25 years and found that caregivers of ovarian cancer patients endure high anxiety, depression, grief, and burnout. The analysis highlighted practical barriers such as financial...

By Medical Xpress
Omada Health Expands Nationwide via OptumRx Weight Engage
SocialApr 30, 2026

Omada Health Expands Nationwide via OptumRx Weight Engage

A milestone for @OmadaHealth: we're now available through @OptumRx's Weight Engage — and with it, employers can purchase Omada through all 3 of the nation's largest PBMs, reaching the majority of commercially insured lives in the U.S. Expanding reach has been...

By Sean Duffy
BIO Panel at HERS Explores Women’s Health Biotech Ecosystem
NewsApr 30, 2026

BIO Panel at HERS Explores Women’s Health Biotech Ecosystem

The Biotechnology Innovation Organization (BIO) convened a panel at the inaugural Health Executive and Research Summit in San Diego to spotlight the women’s health biotech ecosystem. Speakers noted that only six percent of private healthcare investment goes to women’s health,...

By Bio.News
Novartis Finalizes US Expansion with Seventh Facility to Strengthen End-to-End Drug Manufacturing
NewsApr 30, 2026

Novartis Finalizes US Expansion with Seventh Facility to Strengthen End-to-End Drug Manufacturing

Novartas has completed its US expansion plan by adding a seventh facility in Morrisville, North Carolina, dedicated to API production for oral solid‑dose and RNA‑based therapies. The site is part of a $23 billion multi‑year investment to build an end‑to‑end domestic...

By BioPharm International
Eli Lilly Shares Surge on a Beat-and-Raise, Proving the Stock's Swoon Was a Mistake
NewsApr 30, 2026

Eli Lilly Shares Surge on a Beat-and-Raise, Proving the Stock's Swoon Was a Mistake

Eli Lilly reported first‑quarter 2026 revenue of $19.8 billion, up 56% year‑over‑year and well above the $17.6 billion consensus, while adjusted earnings per share jumped to $8.55, more than double the prior year and beating the $6.66 estimate. The strong top‑ and bottom‑line...

By CNBC – Earnings
Redo Mitral Valve Replacement Surgery Outdoes ViV Over the Long Term
NewsApr 30, 2026

Redo Mitral Valve Replacement Surgery Outdoes ViV Over the Long Term

A retrospective analysis of 229 patients treated for failed bioprosthetic mitral valves found that 30‑day mortality and readmission rates were similar for repeat surgical mitral valve replacement (SMVR) and transcatheter valve‑in‑valve (ViV) procedures. However, at five years SMVR patients experienced...

By TCTMD
Rare Myocarditis After mRNA Vaccination: Mitochondrial Stress Identified as a Key Factor
NewsApr 30, 2026

Rare Myocarditis After mRNA Vaccination: Mitochondrial Stress Identified as a Key Factor

Researchers at the University of Tsukuba identified mitochondrial stress as a key driver of the rare myocarditis cases observed after COVID‑19 mRNA vaccination. By analyzing heart biopsies and a mouse model with subclinical mitochondrial impairment, they showed that vaccine lipid...

By Medical Xpress
At UToledo Health, Ambient AI Decreases Open Charts, Improves Documentation
NewsApr 30, 2026

At UToledo Health, Ambient AI Decreases Open Charts, Improves Documentation

UToledo Health piloted Nabla’s ambient AI documentation tool with 40 providers across multiple specialties. Over an eight‑week period the system captured real‑time clinical conversations, generating structured notes that were integrated into Epic, resulting in more than 3,000 documented encounters. The...

By Healthcare IT News (HIMSS Media)
Cigna Sez Sayonara: Another Major Carrier Bailing on ACA Exchanges Next Year
BlogApr 30, 2026

Cigna Sez Sayonara: Another Major Carrier Bailing on ACA Exchanges Next Year

Cigna announced it will exit the individual health‑insurance market under the Affordable Care Act in 2027, leaving roughly 369,000 members in 11 states to find new coverage. The move follows a 17% year‑over‑year drop in Cigna’s ACA enrollment, even as...

By ACA Signups
Disrespectful Attendings Silence Residents, Undermining Patient Safety
SocialApr 30, 2026

Disrespectful Attendings Silence Residents, Undermining Patient Safety

Only 9% of residents will challenge an attending about to harm a patient, if that attending has been disrespectful to them before. When the attending is respectful and patient harm is the only variable, around 20% of residents will speak...

By Kevin Pho, MD
Diabetes Flips Immune Cells From Repair to Inflammation in Peripheral Artery Disease, Study Finds
NewsApr 30, 2026

Diabetes Flips Immune Cells From Repair to Inflammation in Peripheral Artery Disease, Study Finds

A new study published in Science Translational Medicine shows that type 2 diabetes reprograms TREM2‑positive macrophages from a tissue‑repair mode to a pro‑inflammatory state, worsening peripheral artery disease (PAD). Researchers used single‑cell RNA sequencing and spatial transcriptomics on human arteries and...

By Medical Xpress
Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials
NewsApr 30, 2026

Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials

Avalyn Pharma completed a $300 million IPO, pricing 16.6 million shares at $18 each and listing on Nasdaq under the ticker AVLN. The Boston‑based biotech will use the proceeds to advance inhalable versions of pirfenidone (AP01) and nintedanib (AP02), plus a combination...

By MedCity News
Driving Value-Based Practice Transformation Through Care Management
NewsApr 30, 2026

Driving Value-Based Practice Transformation Through Care Management

Community oncology practices are turning to care‑management models such as Principal Care Management, Transitional Care Management, and Principal Illness Navigation to deliver patient‑centric, value‑based care without assuming full financial risk. Real‑world examples—from cCARE in Fresno addressing food insecurity to Rocky...

By AJMC (The American Journal of Managed Care)
Pharma Power Shifts: Controlling Diseases, Not Just Assets
SocialApr 30, 2026

Pharma Power Shifts: Controlling Diseases, Not Just Assets

Most pharma pipeline analysis is spreadsheet theater. I used AI to look at the 2020 → 2026 shift. The real question is not: Who has the most assets? It is: Who controls the disease category? GLP-1s are a metabolic land grab. Oncology is becoming a platform stack. Trials...

By Tatyana Kanzaveli
All Eyes on Fauci as Top Aide Indicted Over Scheme to Hide COVID Emails
BlogApr 30, 2026

All Eyes on Fauci as Top Aide Indicted Over Scheme to Hide COVID Emails

Former NIAID senior adviser Dr. David Morens was indicted on federal charges for conspiring to hide COVID-19-related communications by using private Gmail accounts and deleting records. Prosecutors allege he created a backchannel to Dr. Anthony Fauci to evade FOIA requests...

By The Vigilant Fox
Pharma Pulse: The Ember Cube 2 and a $1 Trillion Prescription Spending Projection for 2026
BlogApr 30, 2026

Pharma Pulse: The Ember Cube 2 and a $1 Trillion Prescription Spending Projection for 2026

Ember LifeSciences unveiled the Ember Cube 2, a modular cold‑chain solution with real‑time monitoring, GPS tracking and cloud visibility, earning a Red Dot “Best of the Best” award. At the Asembia AXS26 summit, policy experts warned that new pricing legislation is compressing post‑launch...

By Pharmaceutical Commerce (independent trade)
Your Oral Microbiome Could Affect Your Weight, Liver and Diabetes Risk
NewsApr 30, 2026

Your Oral Microbiome Could Affect Your Weight, Liver and Diabetes Risk

The study, one of the largest to date, examined the oral microbiome of thousands of participants and found distinct bacterial signatures associated with obesity, pre‑diabetes and non‑alcoholic fatty liver disease. Researchers identified specific taxa whose abundance correlated with insulin resistance...

By New Scientist – Robots
This Gas Provides Rapid Relief For Major & Treatment-Resistant Depression (M)
NewsApr 30, 2026

This Gas Provides Rapid Relief For Major & Treatment-Resistant Depression (M)

Recent clinical investigations show that inhaled nitrous oxide can alleviate symptoms of major depressive disorder, including cases resistant to standard therapies, within hours of administration. Across multiple small‑scale trials, roughly 40% of participants achieved remission after a single session, with...

By PsyBlog
Physician Career Choices Come Down to Risk Tolerance
BlogApr 30, 2026

Physician Career Choices Come Down to Risk Tolerance

Physician career decisions often hinge on risk tolerance, with most doctors opting for stable, modest pay raises (Career A) rather than high‑potential, uncertain roles (Career B). Dr. Stanley Liu argues that a robust financial plan—tax optimization, reserve funds, debt strategies, and contract...

By KevinMD
Surgeon Wears Apple Vision Pro to Fix Cataract in Medical First
NewsApr 30, 2026

Surgeon Wears Apple Vision Pro to Fix Cataract in Medical First

In October 2025, Dr. Eric Rosenberg performed the world’s first cataract surgery using Apple’s Vision Pro mixed‑reality headset paired with a custom ScopeXR app. The system streams 3D microscope feeds to the headset, allowing the surgeon to see a stereoscopic...

By Popular Science
FDA Expedites Review of New HIV Treatment Combo
NewsApr 30, 2026

FDA Expedites Review of New HIV Treatment Combo

The FDA has granted priority review to Gilead Sciences’ new single‑tablet HIV regimen that combines bictegravir and lenacapavir. The application is backed by phase 3 ARTISTRY‑1 and ARTISTRY‑2 trials, which showed sustained viral suppression in adults already virologically controlled. If approved,...

By Healio
Health Systems Add Multiple AI Vendors for Specialty Precision
SocialApr 30, 2026

Health Systems Add Multiple AI Vendors for Specialty Precision

Mayo Clinic partnered with Abridge initially - and now is adding Ambience for specialty care. That’s MORE point solutions - not less. What’s going on here? Recently I spoke to a CMIO whose health system is also planning to add a...

By Joshua Liu, MD
P‑tau217 Blood Test Predicts Alzheimer’s Risk Early
SocialApr 30, 2026

P‑tau217 Blood Test Predicts Alzheimer’s Risk Early

Good summary of p-tau217, the breakthrough blood test to predict risk of Alzheimer's in people well before onset of symptoms @ScienceMagazine https://t.co/qVJtYR4bnz https://t.co/OhjLExTroG

By Eric Topol
FDA Moves to Speed Review Support for Psychedelic-Related Treatments
BlogApr 30, 2026

FDA Moves to Speed Review Support for Psychedelic-Related Treatments

The FDA announced a new fast‑track mechanism for psychedelic‑based therapies, issuing Commissioner’s National Priority Vouchers to three programs targeting depression and PTSD with psilocybin or methylone. It also granted an IND for DemeRx NB to study noribogaine hydrochloride as a...

By Xtalks – Biotech Blogs
Outsourced Teams Can Seamlessly Blend Into Health Systems
SocialApr 30, 2026

Outsourced Teams Can Seamlessly Blend Into Health Systems

Can outsourced teams feel like part of your health system? Gene Scheurer of Optimum Healthcare IT says yes—with secure, branded environments that mirror your organization. Full interview from ViVE 2026 🔗 https://t.co/cPkAwasnxg @OptimumHIT #ViVE2026 #HITSM https://t.co/1cw3rf1g6W

By Colin Hung
O‑1 Model Beats GPT‑4 and Doctors in Triage
SocialApr 30, 2026

O‑1 Model Beats GPT‑4 and Doctors in Triage

New @ScienceMagazine The o-1 reasoning model (text only, from @OpenAI, releasedSept 2024) exceeded performance cf GPT-4 and physicians for clinical vignette management reasoning and in a real-world emergency department assessment for initial triage @AdamRodmanMD @PeterBrodeurMD @arjunmanrai @jonc101x https://t.co/tPZqZAE8cd

By Eric Topol
Trump Replaces Surgeon General Pick with Radiologist Nicole Saphier
SocialApr 30, 2026

Trump Replaces Surgeon General Pick with Radiologist Nicole Saphier

Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier https://t.co/mvCUOymapm via @statnews

By Matthew Herper